Canaccord Adams
http://www.canaccordadams.com/default.htmCanaccord Adams is a leading independent financial services firm committed to fostering the entrepreneurial economy by bringing corporate and institutional clients unique perspective on global investment opportunities. With operations in research, sales and trading, and investment banking, their 225 professionals seek out emerging opportunities in their key sectors - Mining and Metals, Energy, Technology, Life Sciences, Real Estate and Gaming, Consumer and Industrial Growth. Located in nine offices internationally, their experienced team generates focused, actionable ideas that identify opportunity and facilitate growth.
View Older Stories View More Recent Stories
-
Canaccord Adams Maintains a 'Hold' on Superior Well Services (SWSI); Lowers 2011 Estimates
-
Notable Analyst Rating Changes 03/10: ITMN, RDN, EIX, IFSIA Upgraded; FACT, VALE, PSS, NLY, AVAV Downgraded
-
Canaccord Adams Lifts Price Target On Intermune (ITMN) to 'Street High' $66/Share
-
Canaccord Adams Initiates Coverage on China XD Plastics (CXDC) with a Buy; Recent Dip Presents Excellent Buying Opportunity
-
Canaccord Adams Maintains a 'Buy' on Horsehead Holding (ZINC); Raises Estimates & PT
-
Canaccord Adams Maintains a 'Buy' on Texas Instruments (TXN); Raises Estimates
-
Canaccord Adams Maintains a 'Buy' on Northern Oil and Gas (NOG), Raises PT
-
Canaccord Adams Maintains a 'Buy' on Fuel Systems Solutions (FSYS); Tweaks Estimates & PT
-
Canaccord Adams Maintains a 'Buy' on Fuel Tech (FTEK); Raises PT & Estimates
-
SinoHub (SIHI) Completes 1.63M Private Placementat $3.00/Share
-
What is Research In Motion (RIMM) Worth?
-
Canaccord Adams Maintains a 'Buy' on Fuel Systems Solutions (FSYS)
-
Canaccord Adams Reiterates a 'Buy' on Summer Infant (SUMR); Raises PT & Estimates
-
Canaccord Adams Reiterates a 'Hold' on IRIS International (IRIS); Lowers PT & Estimates
-
Canaccord Adams Reiterates a 'Buy' Rating on AMAG Pharmaceuticals (AMAG); Lowers PT
-
Canaccord Adams Maintains a 'Hold' on Allos Therapeutics (ALTH); Raises PT & Estimates
-
Notable Analyst Rating Changes 03/02: DELL, MRVL, SNDK, SQNM Upgraded; KMB, NUHC, OSIP, PALM Downgraded
-
Canaccord Adams Downgrades OSI Pharmaceuticals (OSIP) to Hold on Aggressive Tender Offer
-
Green Energy Could Put Green in Your Wallet - Barron's (CSCO, ABB, GOOG, MSFT, More...)
-
Canaccord Adams Reiterates a 'Buy' Rating on ev3 (EVVV); Added to Best Ideas List
-
Canaccord Adams Maintains a 'Buy' on Fuel Tech (FTEK); Raises PT, Comments on Q4
-
Canaccord Adams Reiterates a 'Buy' on Rosetta Resources (ROSE); Several Catalysts
-
Canaccord Adams Maintains a 'Buy' on Brigham Exploration (BEXP); Announces Positive 2010 Outlook
-
Canaccord Adams Sees Deteriorating Feature Phone Segment at Nokia (NOK), Places Rating Under Review
-
Daily State of the Markets 3/1: Bend But Don't Break
-
Canaccord Adams Lifts Price Target On Research In Motion (RIMM) to $100
-
Canaccord Adams Lifts Q2 Estimates on Apple (AAPL), But Says Verizon iPhone Launch and iPad To Be Delayed
-
Trius Therapeutics (TSRX) Sees IPO Price of $12-$14
-
Canaccord Adams Maintains a 'Buy' on Medicis Pharmaceutical (MRX); Adjusts PT & Estimates
-
Canaccord Adams Maintains a 'Buy' on NuVasive (NUVA); Q4/09 Results Bring More Questions Than Answers; Guidance Complicated
-
Canaccord Adams Maintains a 'Hold' on LKQ Corporation (LKQX); Raise PT & Estimates
-
Canaccord Adams Upgrades 3D Systems (TDSC) to Buy; Q4 upside, Visibility Beginning to Improve
-
Canaccord Adams Upgrades St. Mary Land & Exploration (SM) to Buy
-
Canaccord Adams Maintains a 'Buy' on DigitalGlobe (DGI); Q4 Results Mixed
-
SinoHub (SIHI) Enters SPA for 1.37M Common at $3.00/Share
-
Canaccord Adams Lifts Price Target Dendreon (DNDN) to $47
-
Underwriters Exercise Over-Allotment Option in Labopharm (DDSS) 13.53M Common Offering
-
Notable Analyst Rating Changes 02/19: ADBE, SCHW, WBMD, SFI Upgraded; FSLR, ELGX, WIN, AAP Downgraded
-
Canaccord Adams Reiterates a 'Buy' on Swift Energy (SFY); Year Starting With Momentum
-
Canaccord Adams Maintains a 'Buy' on WebMD Health Corp. (WBMD); Continued Momentum From Major Customer Wins
-
Canaccord Adams Maintains a 'Buy' on Wright Medical Group (WMGI); 2010 Guidance Show Continued Stabilization
-
Canaccord Adams Reiterates a 'Buy' on ev3 Inc. (EVVV); Positive on Q4 Results and Guidance
-
Labopharm (DDSS) Closes Offering of 11.76M Units at $1.70/Unit
-
Notable Analyst Rating Changes 02/18: BEAT, CRM, FSLR, NUE Upgrades; XNPT, CSCX, NTAP, THOR Downgraded
-
Canaccord Adams Reiterates a 'Buy' on Inverness Medical Innovations (IMA); Lowers Estimates & PT
-
Canaccord Adams Reiterates a 'Buy' on Orthofix International (OFIX); Raises PT & Estimates
-
Canaccord Adams Reiterates a 'Buy' on NVIDIA (NVDA); Raises PT & Estimates
-
Canaccord Adams Downgrades NetApp (NTAP) to Hold
-
Notable Analyst Rating Changes 02/17: SNDK, HD, WFMI, ABFS Upgraded; VCLK, SNI, PAAS, CHE Downgraded
-
Canaccord Adams Downgrades ValueClick (VCLK) to Hold
